Tranexamic acid - a useful drug in ENT surgery?

Area of Science:

• Otolaryngology
• Pharmacology

Background:

• Tranexamic acid is a synthetic antifibrinolytic drug with a long history of use.
• Recent adoption in surgical disciplines, including ENT, for bleeding management.
• Epistaxis and post-tonsillectomy bleeding are significant concerns for ENT surgeons.

Purpose of the Study:

• To evaluate the efficacy of tranexamic acid in managing epistaxis.
• To assess the role of tranexamic acid in reducing post-tonsillectomy bleeding.

Main Methods:

• Review of published evidence on tranexamic acid for epistaxis.
• Analysis of pilot studies on tranexamic acid for tonsillectomy bleeding (primary and secondary hemorrhage).

Main Results:

• Evidence suggests tranexamic acid may be helpful in managing epistaxis.
• The prophylactic benefits of tranexamic acid for post-tonsillectomy bleeding are less certain.
• Pilot studies indicate potential efficacy in both pediatric primary and adult secondary hemorrhage.

Conclusions:

• Further large, randomized trials are warranted to explore tranexamic acid's efficacy in routine ENT surgery.
• Potential for reduced patient morbidity and cost savings if efficacy is confirmed.
• Tranexamic acid's role in preventing post-tonsillectomy bleeding requires further investigation.